Biondvax Pharmaceuticals Ltd - ADR
BVXV
Market Cap$888.83K
Close$
$1.86
37% upside
Current Fair Value
37% upsideUndervalued by 37% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $888,827.00 |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $0.0 |
| Beta | 0.42 |
| Outstanding Shares | 653,549 |
| Avg 30 Day Volume | 12,802 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 0.0 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
ESG Score
No data
About Biondvax Pharmaceuticals Ltd
CEO: Ron Babecoff